Cited by 121Plant biochemistry and biosynthesisMicrobial Metabolic Engineering and BioproductionMicrobial Natural Products and Biosynthesis

The DOI matches its Crossref record; 198 of the 199 references it cites were found in a registry or an index.

Engineering Strategies in Microorganisms for the Enhanced Production of Squalene: Advances, Challenges and Opportunities

Open access
Gohil, Nisarg, Bhattacharjee, Gargi, Khambhati, Khushal, Braddick, Darren, Singh, Vijai·2019·Frontiers in Bioengineering and Biotechnology

Abstract

The triterpene squalene is a natural compound that has demonstrated an extraordinary diversity of uses in pharmaceutical, nutraceutical, and personal care industries. Emboldened by this range of uses, novel applications that can gain profit from the benefits of squalene as an additive or supplement are expanding, resulting in its increasing demand. Ever since its discovery, the primary source has been the deep-sea shark liver, although recent declines in their populations and justified animal conservation and protection regulations have encouraged researchers to identify a novel route for squalene biosynthesis. This renewed scientific interest has profited from immense developments in synthetic biology, which now allows fine-tuning of a wider range of plants, fungi, and microorganisms for improved squalene production. There are numerous naturally squalene producing species and strains; although they generally do not make commercially viable yields as primary shark liver sources can deliver. The recent advances made toward improving squalene output from natural and engineered species have inspired this review. Accordingly, it will cover in-depth knowledge offered by the studies of the natural sources, and various engineering-based strategies that have been used to drive the improvements in the pathways toward large-scale production. The wide uses of squalene are also discussed, including the notable developments in anti-cancer applications and in augmenting influenza vaccines for greater efficacy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fbioe.2019.00050

Cites

198 of 198 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 199 references

1 of the 199 references couldn’t be matched to a known paper.

Research works printed but not linked: 6

  1. Bhattacharjee, 2003, Extraction of squalene from yeast by supercritical carbon dioxide, World J. Microbiol. Biotechnol., 19, 605, 10.1023/A:1025146132281 · DOI
  2. Panchasara, 2018, Biosynthetic pathway for production of renewable biofuels, 63
  3. Popa, 2014, Squalene - natural resources and applications, Farmacia, 62, 840
  4. Pora, 2014, Method for the Preparation and Extraction of Squalene From Microalgae.
  5. Tsujiwaki, 1995, Manufacture of squalene with Candida famata, Jpn. Kokai Tokkyo Koho JP, 7, 272
  6. Uragami, 1986, Bacterial production of squalene, Jpn. Kokai Tokkyo Koho JP, 61, 212

Cited by

Sorted by citations

Items 101–121 of 121

Metadata

Authors
Gohil, N., Bhattacharjee, G., Khambhati, K., Braddick, D., & Singh, V.
Affiliations
  • Indian Institute of Advanced Research (IN)
  • Genopole (France) (FR)
Corresponding author
Singh, Vijai
Venue
Frontiers in Bioengineering and Biotechnology
Published
2019-03-22
Volume
7
Pages
114-114
ISSN
2296-4185 (ISSN-L)
OpenAlex
W2924306915
Cited by
121
References
199
Citations by year
2026: 15 · 2025: 15 · 2024: 20 · 2023: 21 · 2022: 19 · 2021: 15 · 2020: 14 · 2019: 2
FWCI
1.10
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Bioengineering and Biotechnology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Plant biochemistry and biosynthesis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Microbial Metabolic Engineering and Bioproduction
  • Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
Keywords
squalene, triterpenoids, synthetic biology, influenza vaccine adjuvants, nutraceuticals, pharmaceutical applications, industrial biotechnology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review